Bioanalytical Systems, Inc. (NASDAQ:BASI) shares passed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $0.00 and traded as high as $2.20. Bioanalytical Systems shares last traded at $2.09, with a volume of 58,306 shares.

Separately, ValuEngine lowered shares of Bioanalytical Systems from a “buy” rating to a “hold” rating in a report on Tuesday, August 6th.

The company has a quick ratio of 0.54, a current ratio of 0.63 and a debt-to-equity ratio of 0.91. The stock’s fifty day moving average price is $2.01 and its two-hundred day moving average price is $1.90.

Bioanalytical Systems (NASDAQ:BASI) last announced its quarterly earnings data on Wednesday, August 14th. The company reported ($0.04) earnings per share for the quarter. The business had revenue of $10.86 million during the quarter. Bioanalytical Systems had a negative return on equity of 3.12% and a negative net margin of 2.82%.

A hedge fund recently raised its stake in Bioanalytical Systems stock. Renaissance Technologies LLC raised its holdings in Bioanalytical Systems, Inc. (NASDAQ:BASI) by 7.7% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 253,001 shares of the company’s stock after buying an additional 18,120 shares during the period. Renaissance Technologies LLC owned about 2.46% of Bioanalytical Systems worth $506,000 as of its most recent filing with the Securities and Exchange Commission. Institutional investors and hedge funds own 6.02% of the company’s stock.

About Bioanalytical Systems (NASDAQ:BASI)

Bioanalytical Systems, Inc provides drug discovery and development services, and analytical instruments for pharmaceutical, biotechnology, academic, and government organizations in the United States, rest of North America, the Pacific Rim, Europe, and internationally. It operates through two segments, Contract Research Services and Research Products.

Featured Story: What is meant by a buy rating?

Receive News & Ratings for Bioanalytical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioanalytical Systems and related companies with's FREE daily email newsletter.